Concepts (337)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pulmonary Aspergillosis | 15 | 2023 | 48 | 8.250 |
Why?
|
Uganda | 59 | 2024 | 1353 | 4.360 |
Why?
|
Antifungal Agents | 16 | 2024 | 769 | 3.500 |
Why?
|
Aspergillus | 9 | 2024 | 93 | 2.670 |
Why?
|
Aspergillosis | 7 | 2024 | 242 | 2.380 |
Why?
|
Mycoses | 6 | 2024 | 389 | 2.370 |
Why?
|
Tuberculosis, Pulmonary | 8 | 2024 | 836 | 2.060 |
Why?
|
Itraconazole | 5 | 2024 | 43 | 1.710 |
Why?
|
Tuberculosis | 8 | 2024 | 2009 | 1.680 |
Why?
|
Tuberculosis, Multidrug-Resistant | 5 | 2024 | 941 | 1.540 |
Why?
|
Tinea Capitis | 2 | 2020 | 16 | 1.430 |
Why?
|
Hospitals, Teaching | 5 | 2024 | 1156 | 1.380 |
Why?
|
Antibodies, Fungal | 5 | 2024 | 33 | 1.380 |
Why?
|
Autopsy | 2 | 2024 | 1011 | 1.370 |
Why?
|
Onychomycosis | 2 | 2022 | 50 | 1.360 |
Why?
|
Health Knowledge, Attitudes, Practice | 7 | 2024 | 4055 | 1.270 |
Why?
|
Africa | 10 | 2024 | 725 | 1.210 |
Why?
|
HIV Infections | 18 | 2024 | 17531 | 1.070 |
Why?
|
Antitubercular Agents | 6 | 2024 | 1380 | 1.050 |
Why?
|
Immunoglobulin G | 7 | 2024 | 4555 | 1.030 |
Why?
|
Health Personnel | 3 | 2024 | 3385 | 0.940 |
Why?
|
Trichophyton | 2 | 2022 | 21 | 0.940 |
Why?
|
Immunoglobulin M | 4 | 2024 | 1527 | 0.930 |
Why?
|
AIDS-Related Opportunistic Infections | 4 | 2023 | 663 | 0.930 |
Why?
|
Prevalence | 25 | 2024 | 15828 | 0.890 |
Why?
|
Hemorrhagic Fevers, Viral | 1 | 2023 | 23 | 0.840 |
Why?
|
Candidiasis, Vulvovaginal | 1 | 2022 | 25 | 0.800 |
Why?
|
Cross-Sectional Studies | 33 | 2024 | 26282 | 0.780 |
Why?
|
Wilms Tumor | 2 | 2023 | 378 | 0.770 |
Why?
|
Refugees | 3 | 2024 | 615 | 0.770 |
Why?
|
Cryptococcosis | 2 | 2024 | 99 | 0.770 |
Why?
|
Hypertriglyceridemia | 1 | 2024 | 292 | 0.720 |
Why?
|
Hyperphagia | 1 | 2021 | 139 | 0.720 |
Why?
|
Ebolavirus | 1 | 2023 | 250 | 0.690 |
Why?
|
Horner Syndrome | 1 | 2020 | 35 | 0.680 |
Why?
|
Peptic Ulcer Perforation | 1 | 2019 | 23 | 0.680 |
Why?
|
Tuberculosis, Meningeal | 1 | 2020 | 49 | 0.660 |
Why?
|
Contact Tracing | 1 | 2022 | 274 | 0.650 |
Why?
|
Living Donors | 1 | 2024 | 647 | 0.650 |
Why?
|
Dyslipidemias | 2 | 2024 | 871 | 0.650 |
Why?
|
Diabetes Mellitus | 5 | 2024 | 5889 | 0.640 |
Why?
|
Aspergillus nidulans | 1 | 2018 | 8 | 0.640 |
Why?
|
Triazoles | 3 | 2019 | 898 | 0.640 |
Why?
|
Aspergillus flavus | 1 | 2018 | 13 | 0.630 |
Why?
|
Drug Resistance, Fungal | 2 | 2023 | 79 | 0.630 |
Why?
|
Consensus Development Conferences as Topic | 1 | 2019 | 168 | 0.620 |
Why?
|
Aspergillus fumigatus | 2 | 2021 | 158 | 0.600 |
Why?
|
Hospitals, University | 1 | 2020 | 573 | 0.590 |
Why?
|
Self-Injurious Behavior | 1 | 2024 | 572 | 0.590 |
Why?
|
Universities | 3 | 2023 | 1004 | 0.580 |
Why?
|
Mediastinal Neoplasms | 1 | 2021 | 403 | 0.580 |
Why?
|
Teratoma | 1 | 2021 | 402 | 0.580 |
Why?
|
Malnutrition | 1 | 2024 | 629 | 0.580 |
Why?
|
Informed Consent | 1 | 2024 | 1010 | 0.580 |
Why?
|
Hemorrhagic Fever, Ebola | 1 | 2023 | 424 | 0.570 |
Why?
|
Diagnostic Techniques and Procedures | 1 | 2019 | 216 | 0.570 |
Why?
|
Dental Caries | 1 | 2021 | 429 | 0.570 |
Why?
|
Fluconazole | 1 | 2018 | 154 | 0.560 |
Why?
|
Cryptococcus neoformans | 1 | 2018 | 110 | 0.560 |
Why?
|
Research Report | 1 | 2020 | 367 | 0.560 |
Why?
|
Humans | 109 | 2024 | 765926 | 0.550 |
Why?
|
Contraceptive Agents | 1 | 2018 | 147 | 0.540 |
Why?
|
Oral Health | 1 | 2021 | 493 | 0.510 |
Why?
|
Communicable Diseases, Emerging | 1 | 2017 | 149 | 0.510 |
Why?
|
Students | 3 | 2023 | 1741 | 0.510 |
Why?
|
Tissue and Organ Procurement | 1 | 2024 | 988 | 0.500 |
Why?
|
Occupational Diseases | 1 | 2023 | 1456 | 0.500 |
Why?
|
Candidiasis | 1 | 2018 | 372 | 0.490 |
Why?
|
Anemia | 2 | 2022 | 1514 | 0.490 |
Why?
|
Chronic Disease | 11 | 2023 | 9351 | 0.480 |
Why?
|
Mycology | 3 | 2024 | 13 | 0.480 |
Why?
|
Young Adult | 28 | 2024 | 59857 | 0.460 |
Why?
|
Adult | 47 | 2024 | 223088 | 0.440 |
Why?
|
Income | 2 | 2023 | 1874 | 0.440 |
Why?
|
Nitriles | 1 | 2019 | 981 | 0.430 |
Why?
|
Meta-Analysis as Topic | 3 | 2023 | 1366 | 0.430 |
Why?
|
Aspergillosis, Allergic Bronchopulmonary | 2 | 2024 | 12 | 0.420 |
Why?
|
Burnout, Professional | 1 | 2021 | 710 | 0.410 |
Why?
|
Female | 56 | 2024 | 396141 | 0.400 |
Why?
|
Cost-Benefit Analysis | 2 | 2024 | 5531 | 0.380 |
Why?
|
Weight Gain | 1 | 2021 | 2356 | 0.370 |
Why?
|
Adolescent | 22 | 2024 | 88811 | 0.370 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 2019 | 2204 | 0.350 |
Why?
|
Students, Medical | 2 | 2022 | 1962 | 0.350 |
Why?
|
Microbial Sensitivity Tests | 4 | 2023 | 1970 | 0.350 |
Why?
|
Male | 46 | 2024 | 363815 | 0.350 |
Why?
|
Developing Countries | 3 | 2021 | 2913 | 0.340 |
Why?
|
Neglected Diseases | 2 | 2021 | 67 | 0.340 |
Why?
|
Histoplasmosis | 2 | 2021 | 63 | 0.330 |
Why?
|
Disease Management | 1 | 2020 | 2530 | 0.330 |
Why?
|
Isoniazid | 2 | 2021 | 279 | 0.320 |
Why?
|
Weight Loss | 1 | 2020 | 2710 | 0.310 |
Why?
|
Laparotomy | 2 | 2022 | 459 | 0.310 |
Why?
|
Quality of Life | 4 | 2021 | 13463 | 0.310 |
Why?
|
Retrospective Studies | 21 | 2024 | 81537 | 0.300 |
Why?
|
Hypertension | 3 | 2023 | 8616 | 0.300 |
Why?
|
Kidney Neoplasms | 2 | 2023 | 4278 | 0.290 |
Why?
|
Fungi | 4 | 2023 | 347 | 0.290 |
Why?
|
Sequence Analysis, DNA | 1 | 2018 | 4780 | 0.290 |
Why?
|
Immunoglobulin E | 3 | 2024 | 1479 | 0.280 |
Why?
|
Pyridines | 1 | 2019 | 2885 | 0.270 |
Why?
|
Histoplasma | 3 | 2023 | 40 | 0.260 |
Why?
|
Anemia, Sickle Cell | 2 | 2024 | 1063 | 0.260 |
Why?
|
Pandemics | 4 | 2023 | 8721 | 0.250 |
Why?
|
Diagnostic Tests, Routine | 3 | 2022 | 788 | 0.250 |
Why?
|
Liver Neoplasms | 1 | 2021 | 4349 | 0.240 |
Why?
|
Prenatal Care | 2 | 2024 | 1158 | 0.240 |
Why?
|
International Cooperation | 2 | 2023 | 1433 | 0.240 |
Why?
|
Middle Aged | 23 | 2024 | 223016 | 0.240 |
Why?
|
Schools, Medical | 2 | 2022 | 882 | 0.230 |
Why?
|
Invasive Pulmonary Aspergillosis | 1 | 2024 | 18 | 0.230 |
Why?
|
Risk Factors | 13 | 2024 | 74850 | 0.220 |
Why?
|
Azoles | 1 | 2023 | 23 | 0.220 |
Why?
|
Suicidal Ideation | 2 | 2024 | 1465 | 0.220 |
Why?
|
Helminths | 1 | 2023 | 39 | 0.210 |
Why?
|
Pregnancy in Adolescence | 1 | 2024 | 164 | 0.210 |
Why?
|
Hepatitis B Vaccines | 1 | 2024 | 178 | 0.210 |
Why?
|
Mucormycosis | 1 | 2024 | 104 | 0.200 |
Why?
|
Helminthiasis | 1 | 2023 | 81 | 0.200 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3109 | 0.200 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3231 | 0.200 |
Why?
|
Antigens, Fungal | 2 | 2021 | 69 | 0.200 |
Why?
|
Child | 15 | 2024 | 80568 | 0.200 |
Why?
|
Meningitis, Cryptococcal | 2 | 2024 | 65 | 0.200 |
Why?
|
Serologic Tests | 1 | 2024 | 382 | 0.200 |
Why?
|
Students, Health Occupations | 1 | 2022 | 30 | 0.190 |
Why?
|
Drugs, Essential | 1 | 2022 | 71 | 0.190 |
Why?
|
Pregnancy | 9 | 2024 | 30230 | 0.190 |
Why?
|
Tumor Lysis Syndrome | 1 | 2021 | 38 | 0.190 |
Why?
|
Zenker Diverticulum | 1 | 2021 | 28 | 0.190 |
Why?
|
Candida | 1 | 2022 | 174 | 0.190 |
Why?
|
Nigeria | 2 | 2022 | 782 | 0.180 |
Why?
|
Mentors | 2 | 2023 | 671 | 0.180 |
Why?
|
Lung Diseases, Fungal | 1 | 2021 | 123 | 0.180 |
Why?
|
Fetal Weight | 1 | 2021 | 90 | 0.180 |
Why?
|
Private Sector | 1 | 2024 | 396 | 0.180 |
Why?
|
Mycetoma | 1 | 2020 | 18 | 0.170 |
Why?
|
Term Birth | 1 | 2021 | 140 | 0.170 |
Why?
|
Retreatment | 1 | 2022 | 598 | 0.170 |
Why?
|
Ethiopia | 1 | 2022 | 485 | 0.170 |
Why?
|
Sensitivity and Specificity | 4 | 2023 | 14643 | 0.170 |
Why?
|
Echinocandins | 1 | 2020 | 57 | 0.170 |
Why?
|
Ethambutol | 1 | 2020 | 59 | 0.170 |
Why?
|
Hemoptysis | 1 | 2021 | 151 | 0.170 |
Why?
|
Pyrazinamide | 1 | 2020 | 60 | 0.170 |
Why?
|
Cardiovascular Diseases | 2 | 2022 | 15645 | 0.170 |
Why?
|
Immunocompetence | 1 | 2020 | 138 | 0.170 |
Why?
|
Pyridoxine | 1 | 2020 | 108 | 0.170 |
Why?
|
Sputum | 2 | 2021 | 513 | 0.170 |
Why?
|
Mediastinum | 1 | 2021 | 271 | 0.160 |
Why?
|
Reference Standards | 1 | 2023 | 1011 | 0.160 |
Why?
|
Lymphangioleiomyomatosis | 1 | 2021 | 206 | 0.160 |
Why?
|
Referral and Consultation | 3 | 2022 | 3615 | 0.160 |
Why?
|
Candida albicans | 1 | 2022 | 377 | 0.160 |
Why?
|
Nuts | 1 | 2021 | 265 | 0.160 |
Why?
|
Algorithms | 1 | 2019 | 14064 | 0.160 |
Why?
|
Neoplasms | 3 | 2023 | 22340 | 0.160 |
Why?
|
Diabetic Neuropathies | 1 | 2022 | 407 | 0.160 |
Why?
|
Burkitt Lymphoma | 1 | 2021 | 338 | 0.160 |
Why?
|
Public Health | 2 | 2023 | 2680 | 0.160 |
Why?
|
Diabetic Foot | 1 | 2022 | 383 | 0.150 |
Why?
|
Amphotericin B | 1 | 2018 | 140 | 0.150 |
Why?
|
Hepatitis B | 1 | 2024 | 709 | 0.150 |
Why?
|
Thinness | 1 | 2022 | 482 | 0.150 |
Why?
|
Aged, 80 and over | 9 | 2022 | 59496 | 0.150 |
Why?
|
Immunoenzyme Techniques | 1 | 2021 | 1695 | 0.150 |
Why?
|
Suicide, Attempted | 2 | 2024 | 1412 | 0.150 |
Why?
|
Rifampin | 1 | 2020 | 350 | 0.150 |
Why?
|
Abortion, Induced | 1 | 2024 | 471 | 0.140 |
Why?
|
Aftercare | 1 | 2024 | 915 | 0.140 |
Why?
|
Immunoassay | 1 | 2021 | 742 | 0.140 |
Why?
|
Nucleic Acid Amplification Techniques | 1 | 2020 | 335 | 0.140 |
Why?
|
Musculoskeletal Diseases | 1 | 2023 | 598 | 0.140 |
Why?
|
Cholesterol, HDL | 1 | 2024 | 1813 | 0.140 |
Why?
|
Genes, Fungal | 1 | 2018 | 441 | 0.140 |
Why?
|
Treatment Outcome | 6 | 2021 | 65194 | 0.140 |
Why?
|
Recurrence | 2 | 2021 | 8492 | 0.140 |
Why?
|
Home Care Services | 1 | 2023 | 658 | 0.140 |
Why?
|
Microscopy | 2 | 2023 | 900 | 0.140 |
Why?
|
Microbiological Techniques | 1 | 2017 | 96 | 0.140 |
Why?
|
Patient Acceptance of Health Care | 3 | 2024 | 3230 | 0.130 |
Why?
|
Cost of Illness | 3 | 2020 | 1949 | 0.130 |
Why?
|
Retinal Diseases | 1 | 2022 | 702 | 0.130 |
Why?
|
Contraception Behavior | 1 | 2018 | 185 | 0.130 |
Why?
|
Rheumatic Diseases | 1 | 2023 | 657 | 0.130 |
Why?
|
Adolescent Behavior | 1 | 2024 | 1184 | 0.130 |
Why?
|
Interdisciplinary Communication | 1 | 2021 | 931 | 0.120 |
Why?
|
Deglutition Disorders | 1 | 2021 | 640 | 0.120 |
Why?
|
Cesarean Section | 1 | 2024 | 1418 | 0.120 |
Why?
|
Eosinophils | 1 | 2020 | 946 | 0.120 |
Why?
|
Anti-Infective Agents | 1 | 2022 | 985 | 0.120 |
Why?
|
Causality | 1 | 2021 | 1247 | 0.120 |
Why?
|
Neoplasms, Second Primary | 1 | 2023 | 1056 | 0.120 |
Why?
|
Metformin | 1 | 2022 | 904 | 0.120 |
Why?
|
Aged | 11 | 2024 | 171163 | 0.120 |
Why?
|
Pneumonectomy | 1 | 2021 | 1128 | 0.110 |
Why?
|
Organ Transplantation | 1 | 2024 | 1172 | 0.110 |
Why?
|
Tanzania | 1 | 2018 | 1407 | 0.110 |
Why?
|
Survivors | 1 | 2024 | 2373 | 0.110 |
Why?
|
Rural Population | 1 | 2024 | 2318 | 0.110 |
Why?
|
Disease Outbreaks | 1 | 2023 | 1761 | 0.110 |
Why?
|
Radiography, Thoracic | 1 | 2019 | 1319 | 0.100 |
Why?
|
Mass Vaccination | 1 | 2014 | 111 | 0.100 |
Why?
|
Adaptation, Psychological | 1 | 2023 | 2662 | 0.100 |
Why?
|
Infection Control | 1 | 2020 | 984 | 0.100 |
Why?
|
Ultrasonography, Prenatal | 1 | 2021 | 1772 | 0.100 |
Why?
|
Birth Weight | 1 | 2021 | 2122 | 0.100 |
Why?
|
Administration, Oral | 1 | 2020 | 4016 | 0.100 |
Why?
|
Endoscopy | 2 | 2021 | 1854 | 0.100 |
Why?
|
Lung Transplantation | 1 | 2021 | 1311 | 0.100 |
Why?
|
Schools | 1 | 2020 | 1496 | 0.100 |
Why?
|
Peripheral Arterial Disease | 1 | 2022 | 1308 | 0.090 |
Why?
|
Antibodies, Viral | 1 | 2022 | 3213 | 0.090 |
Why?
|
Health Occupations | 2 | 2022 | 226 | 0.090 |
Why?
|
Socioeconomic Factors | 2 | 2022 | 7842 | 0.090 |
Why?
|
Anti-Retroviral Agents | 1 | 2019 | 1786 | 0.080 |
Why?
|
Radiography | 1 | 2021 | 6941 | 0.080 |
Why?
|
Emotions | 1 | 2021 | 2759 | 0.080 |
Why?
|
Blood Glucose | 1 | 2024 | 6422 | 0.080 |
Why?
|
Genetic Loci | 1 | 2018 | 2630 | 0.080 |
Why?
|
Critical Illness | 1 | 2022 | 2749 | 0.080 |
Why?
|
Kidney | 1 | 2024 | 7073 | 0.080 |
Why?
|
Liver | 1 | 2024 | 7559 | 0.080 |
Why?
|
Postoperative Complications | 2 | 2022 | 15802 | 0.080 |
Why?
|
Laboratories | 2 | 2023 | 463 | 0.080 |
Why?
|
Intensive Care Units | 1 | 2022 | 3799 | 0.080 |
Why?
|
Mass Screening | 2 | 2021 | 5449 | 0.080 |
Why?
|
Stress, Psychological | 1 | 2023 | 4527 | 0.070 |
Why?
|
Papillomavirus Vaccines | 1 | 2014 | 495 | 0.070 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2022 | 12235 | 0.070 |
Why?
|
Dementia | 1 | 2022 | 2741 | 0.070 |
Why?
|
Poverty | 1 | 2019 | 2714 | 0.070 |
Why?
|
Ambulatory Care | 1 | 2018 | 2778 | 0.070 |
Why?
|
Anti-Bacterial Agents | 2 | 2023 | 7473 | 0.070 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2023 | 3637 | 0.070 |
Why?
|
Body Weight | 1 | 2018 | 4627 | 0.070 |
Why?
|
Depression | 2 | 2024 | 8223 | 0.070 |
Why?
|
Research Design | 1 | 2023 | 6204 | 0.070 |
Why?
|
Logistic Models | 1 | 2022 | 13273 | 0.070 |
Why?
|
Lung Neoplasms | 2 | 2022 | 13446 | 0.070 |
Why?
|
Tomography, X-Ray Computed | 2 | 2021 | 20690 | 0.070 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2021 | 3444 | 0.070 |
Why?
|
Prospective Studies | 5 | 2023 | 54807 | 0.070 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2022 | 4044 | 0.070 |
Why?
|
Diet | 1 | 2024 | 8087 | 0.070 |
Why?
|
Acute Kidney Injury | 1 | 2018 | 1943 | 0.060 |
Why?
|
Diagnosis, Differential | 1 | 2021 | 12973 | 0.060 |
Why?
|
Epilepsy | 1 | 2021 | 3317 | 0.060 |
Why?
|
Hospitals | 3 | 2023 | 3886 | 0.060 |
Why?
|
Cognition | 1 | 2022 | 7043 | 0.060 |
Why?
|
Fetal Distress | 1 | 2024 | 39 | 0.060 |
Why?
|
CD4 Lymphocyte Count | 2 | 2021 | 2586 | 0.060 |
Why?
|
Adenocarcinoma | 1 | 2022 | 6360 | 0.060 |
Why?
|
Labor Presentation | 1 | 2024 | 54 | 0.060 |
Why?
|
Inflammation | 1 | 2024 | 10843 | 0.060 |
Why?
|
Animals | 4 | 2023 | 168735 | 0.060 |
Why?
|
Agar | 1 | 2023 | 51 | 0.060 |
Why?
|
Sudan | 1 | 2023 | 86 | 0.050 |
Why?
|
Obesity | 2 | 2022 | 13082 | 0.050 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2022 | 5379 | 0.050 |
Why?
|
Prednisolone | 1 | 2024 | 323 | 0.050 |
Why?
|
Private Practice | 1 | 2024 | 154 | 0.050 |
Why?
|
Aspartate Aminotransferases | 1 | 2024 | 416 | 0.050 |
Why?
|
United Nations | 1 | 2023 | 151 | 0.050 |
Why?
|
Soil | 1 | 2023 | 119 | 0.050 |
Why?
|
Apgar Score | 1 | 2022 | 125 | 0.050 |
Why?
|
Sex Factors | 3 | 2021 | 10611 | 0.050 |
Why?
|
Asthma | 1 | 2021 | 6268 | 0.050 |
Why?
|
Papillomavirus Infections | 1 | 2014 | 1637 | 0.050 |
Why?
|
Glyburide | 1 | 2022 | 117 | 0.050 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2014 | 2040 | 0.050 |
Why?
|
Alanine Transaminase | 1 | 2024 | 608 | 0.050 |
Why?
|
Infant | 2 | 2021 | 36426 | 0.050 |
Why?
|
Alkaline Phosphatase | 1 | 2024 | 855 | 0.050 |
Why?
|
Viral Load | 2 | 2021 | 3385 | 0.050 |
Why?
|
Cameroon | 1 | 2021 | 79 | 0.050 |
Why?
|
Parity | 1 | 2024 | 931 | 0.050 |
Why?
|
Spirometry | 1 | 2024 | 929 | 0.050 |
Why?
|
Kenya | 1 | 2024 | 758 | 0.050 |
Why?
|
Child, Preschool | 2 | 2021 | 42510 | 0.050 |
Why?
|
Maternal Mortality | 1 | 2024 | 310 | 0.040 |
Why?
|
Family Planning Services | 1 | 2024 | 277 | 0.040 |
Why?
|
Actinomycetaceae | 1 | 2020 | 5 | 0.040 |
Why?
|
Nocardia | 1 | 2020 | 9 | 0.040 |
Why?
|
Tropical Climate | 1 | 2020 | 35 | 0.040 |
Why?
|
Hepatitis B virus | 1 | 2024 | 532 | 0.040 |
Why?
|
Cardiomegaly | 1 | 2023 | 590 | 0.040 |
Why?
|
Africa South of the Sahara | 1 | 2023 | 751 | 0.040 |
Why?
|
North America | 1 | 2023 | 1287 | 0.040 |
Why?
|
Respiratory Function Tests | 1 | 2024 | 1692 | 0.040 |
Why?
|
Obesity, Abdominal | 1 | 2022 | 370 | 0.040 |
Why?
|
Fungal Proteins | 1 | 2023 | 900 | 0.040 |
Why?
|
Laboratories, Hospital | 1 | 2020 | 192 | 0.040 |
Why?
|
Incidence | 3 | 2024 | 21513 | 0.040 |
Why?
|
Proportional Hazards Models | 2 | 2024 | 12529 | 0.040 |
Why?
|
Body Size | 1 | 2021 | 460 | 0.040 |
Why?
|
Pilot Projects | 2 | 2021 | 8724 | 0.040 |
Why?
|
Program Development | 1 | 2023 | 1297 | 0.040 |
Why?
|
Attitude | 1 | 2022 | 768 | 0.040 |
Why?
|
Body Temperature | 1 | 2020 | 781 | 0.030 |
Why?
|
Area Under Curve | 1 | 2021 | 1637 | 0.030 |
Why?
|
Infant, Newborn | 3 | 2022 | 26380 | 0.030 |
Why?
|
Costs and Cost Analysis | 1 | 2022 | 1666 | 0.030 |
Why?
|
Gestational Age | 1 | 2024 | 3616 | 0.030 |
Why?
|
Drug Resistance, Bacterial | 1 | 2022 | 1065 | 0.030 |
Why?
|
Program Evaluation | 1 | 2023 | 2502 | 0.030 |
Why?
|
Sexual Behavior | 1 | 2024 | 2192 | 0.030 |
Why?
|
Statistics as Topic | 1 | 2021 | 2350 | 0.030 |
Why?
|
Lung Diseases | 1 | 2024 | 1939 | 0.030 |
Why?
|
Diagnostic Errors | 1 | 2021 | 1276 | 0.030 |
Why?
|
ROC Curve | 1 | 2021 | 3612 | 0.030 |
Why?
|
Brain | 1 | 2020 | 27179 | 0.030 |
Why?
|
Qualitative Research | 1 | 2023 | 3136 | 0.030 |
Why?
|
Polymerase Chain Reaction | 1 | 2021 | 6058 | 0.020 |
Why?
|
Inpatients | 1 | 2023 | 2563 | 0.020 |
Why?
|
Lipids | 1 | 2022 | 3317 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2018 | 3801 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2022 | 6503 | 0.020 |
Why?
|
Critical Care | 1 | 2023 | 2713 | 0.020 |
Why?
|
Outpatients | 1 | 2018 | 1595 | 0.020 |
Why?
|
Linear Models | 1 | 2020 | 5873 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2021 | 5300 | 0.020 |
Why?
|
Seizures | 1 | 2022 | 2997 | 0.020 |
Why?
|
Anxiety | 1 | 2023 | 4669 | 0.020 |
Why?
|
Insulin | 1 | 2022 | 6603 | 0.020 |
Why?
|
Survival Rate | 1 | 2022 | 12822 | 0.020 |
Why?
|
Blood Pressure | 1 | 2023 | 8530 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2023 | 14745 | 0.020 |
Why?
|
Case-Control Studies | 1 | 2024 | 22228 | 0.020 |
Why?
|
Phenotype | 1 | 2023 | 16714 | 0.020 |
Why?
|
Health Services Accessibility | 1 | 2022 | 5509 | 0.010 |
Why?
|
Hospitalization | 1 | 2024 | 10810 | 0.010 |
Why?
|
Age Factors | 1 | 2020 | 18382 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2021 | 9373 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2018 | 7423 | 0.010 |
Why?
|
Prognosis | 1 | 2021 | 29890 | 0.010 |
Why?
|
Cohort Studies | 1 | 2021 | 41680 | 0.010 |
Why?
|
Concepts
(337)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(2)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_